Glaukos Corporation (GKOS) is in Healthcare, Medical Devices, based in United States, listed on NYSE. Market cap 9.51B USD. 52-week range 73.16 to 191.62 USD. Data as of 2026-10-09.
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of ...